Epidemiology and updated management for autoimmune liver disease.
作者信息
Heo Nae-Yun, Kim Haeryoung
机构信息
Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2023 Jan;29(1):194-196. doi: 10.3350/cmh.2022.0387. Epub 2022 Dec 14.
Abstract
摘要
相似文献
1
Epidemiology and updated management for autoimmune liver disease.
Clin Mol Hepatol. 2023 Jan;29(1):194-196. doi: 10.3350/cmh.2022.0387. Epub 2022 Dec 14.
2
Revised criteria for diagnosis of autoimmune hepatitis.
Intern Med. 2000 Dec;39(12):999-1000. doi: 10.2169/internalmedicine.39.999.
3
[Epidemiology of Autoimmune Liver Disease].
Korean J Gastroenterol. 2023 Feb 25;81(2):59-65. doi: 10.4166/kjg.2023.007.
4
[Research advances of autoimmune liver diseases in 2018].
Zhonghua Gan Zang Bing Za Zhi. 2019 Jan 20;27(1):14-17. doi: 10.3760/cma.j.issn.1007-3418.2019.01.005.
5
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives.
Clin Exp Med. 2023 Nov;23(7):3321-3338. doi: 10.1007/s10238-023-01128-8. Epub 2023 Jul 8.
6
Epidemiology of autoimmune liver disease.
J Gastroenterol Hepatol. 2003 Oct;18(10):1118-28. doi: 10.1046/j.1440-1746.2003.03165.x.
7
Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis.
Pediatr Clin North Am. 2021 Dec;68(6):1293-1307. doi: 10.1016/j.pcl.2021.07.006.
8
UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER.
Arq Gastroenterol. 2019 Aug 13;56(2):232-241. doi: 10.1590/S0004-2803.201900000-43.
9
Autoimmune liver diseases and diabetes.
Eur J Gastroenterol Hepatol. 2023 Sep 1;35(9):938-947. doi: 10.1097/MEG.0000000000002594. Epub 2023 Jun 22.
10
Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective.
Eur J Gastroenterol Hepatol. 2005 Oct;17(10):1077-80. doi: 10.1097/00042737-200510000-00011.
引用本文的文献
1
Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review.
Int J Mol Sci. 2025 Feb 22;26(5):1883. doi: 10.3390/ijms26051883.
2
A Closer Look into Autoimmune Liver Diseases.
Int J Mol Sci. 2025 Feb 21;26(5):1863. doi: 10.3390/ijms26051863.
3
Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study.
JHEP Rep. 2024 Nov 6;7(2):101251. doi: 10.1016/j.jhepr.2024.101251. eCollection 2025 Feb.
4
Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells.
J Clin Transl Hepatol. 2024 Jul 28;12(7):659-666. doi: 10.14218/JCTH.2023.00531. Epub 2024 May 28.
5
JCAD, a new potential therapeutic target in cholestatic liver disease.
Clin Mol Hepatol. 2024 Apr;30(2):166-167. doi: 10.3350/cmh.2024.0128. Epub 2024 Mar 8.
6
Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis.
Clin Mol Hepatol. 2024 Apr;30(2):157-159. doi: 10.3350/cmh.2024.0131. Epub 2024 Feb 23.
7
Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center.
BMC Gastroenterol. 2024 Jan 4;24(1):17. doi: 10.1186/s12876-023-03105-7.
8
Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity.
Clin Mol Hepatol. 2024 Jan;30(1):37-48. doi: 10.3350/cmh.2023.0325. Epub 2023 Nov 13.
本文引用的文献
1
Recent updates on the management of autoimmune hepatitis.
Clin Mol Hepatol. 2021 Jan;27(1):58-69. doi: 10.3350/cmh.2020.0189. Epub 2020 Dec 10.
2
Current understanding of primary biliary cholangitis.
Clin Mol Hepatol. 2021 Jan;27(1):1-21. doi: 10.3350/cmh.2020.0028. Epub 2020 Dec 3.
3
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.
Hepatology. 2020 Aug;72(2):671-722. doi: 10.1002/hep.31065. Epub 2020 May 12.
4
Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population.
J Gastroenterol Hepatol. 2019 Oct;34(10):1676-1684. doi: 10.1111/jgh.14746. Epub 2019 Jul 7.
5
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis.
Hepatology. 2019 Dec;70(6):2035-2046. doi: 10.1002/hep.30552. Epub 2019 Apr 12.
6
IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.
Gut Liver. 2019 May 15;13(3):300-307. doi: 10.5009/gnl18085.
7
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
N Engl J Med. 2018 Jun 7;378(23):2171-2181. doi: 10.1056/NEJMoa1714519.
8
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment.
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1342-1350.e1. doi: 10.1016/j.cgh.2017.12.033. Epub 2017 Dec 23.
9
Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea.
PLoS One. 2017 Aug 3;12(8):e0182391. doi: 10.1371/journal.pone.0182391. eCollection 2017.
10
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.
Nat Genet. 2016 Apr;48(4):367-73. doi: 10.1038/ng.3508. Epub 2016 Feb 15.
Zotero 插件